Precision radiation treatment can delay treatment escalation in men with metastatic prostate cancer without leading to severe toxicity, according to a landmark Australian study.

For the trial — the world’s largest and first to include patients with up to five metastatic lesions — almost 200 men were treated using stereotactic body radiation therapy, Melbourne’s Icon Cancer Centre-led researchers report in the International Journal of Cancer.